Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma

Primary effusion lymphoma (PEL) is a rare aggressive subset of non-Hodgkin B cell lymphoma. PEL is secondary to Kaposi sarcoma herpes virus (KSHV) and predominantly develops in serous cavities. Conventional chemotherapy remains the treatment of choice for PEL and yields high response rates with no s...

Descripción completa

Detalles Bibliográficos
Autores principales: Moodad, Sara, El Hajj, Rana, Hleihel, Rita, Hajjar, Layal, Tawil, Nadim, Karam, Martin, Hamie, Maguy, Abou Merhi, Raghida, El Sabban, Marwan, El Hajj, Hiba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563318/
https://www.ncbi.nlm.nih.gov/pubmed/32883022
http://dx.doi.org/10.3390/cancers12092483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563318/
https://www.ncbi.nlm.nih.gov/pubmed/32883022
http://dx.doi.org/10.3390/cancers12092483

Ejemplares similares